Journal of Policy and Practice in Intellectual Disabilities, published by WILEY, stands as a prominent platform dedicated to advancing our understanding and application of policies and practices that affect individuals with intellectual disabilities. Established in 2009, this esteemed journal addresses critical issues in the field of social sciences, primarily focusing on health and public health, evident from its high rankings in Q1 and Q2 categories in the 2023 metrics. With an ISSN of 1741-1122 and an E-ISSN of 1741-1130, it operates out of the United Kingdom, offering vital insights that inform service delivery, policy-making, and research initiatives surrounding intellectual disabilities. Though not an open access journal, it provides a rich resource for researchers, professionals, and students aiming to contribute to meaningful change in this vital area of social welfare. The journal’s commitment to rigorous scholarship is reflected in its Scopus rankings, highlighting its influence as a pivotal resource for those seeking to enhance and innovate practices that uplift community well-being.

European Journal of Health Psychology (ISSN: 2512-8442, E-ISSN: 2512-8450), published by HOGREFE PUBLISHING CORP, is a premier platform for researchers and professionals in the fields of clinical psychology, psychiatry, and health psychology. Based in Germany, this journal publishes insightful articles that advance understanding of mental health and psychological well-being, aiming to bridge the gap between research and practical application. With a commendable Q2 ranking in Clinical Psychology and a Q3 ranking in Psychiatry and Mental Health for 2023, it highlights its significance within the academic community. The journal covers a diverse range of topics and caters to the evolving needs of the field, making it an essential resource for students, researchers, and practitioners alike. Although it operates under a traditional access model, its commitment to high-quality, peer-reviewed content ensures it remains a crucial repository of knowledge within the ecosystem of health psychology.

The Journal of Applied Research in Intellectual Disabilities, published by Wiley, is a pioneering platform dedicated to advancing knowledge and promoting best practices in the field of intellectual disabilities. With an impressive impact factor reflecting its significance—ranking in the Q2 category for Developmental and Educational Psychology and the Q1 category for Education in 2023—this journal serves as an essential resource for researchers, practitioners, and students alike. Its wide contribution to social sciences is evidenced by its high standings in Scopus rankings, positioned at Rank #297 in Education and Rank #103 in Developmental and Educational Psychology. This journal not only fosters innovative empirical and theoretical research but also encourages the dissemination of practical solutions to enhance the quality of life for individuals with intellectual disabilities. With access options available to meet diverse needs, including open access, it strives to make impactful research widely available, bridging the gap between academic research and practical application.

PSYCHIATRISCHE PRAXIS, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a vital resource in the field of psychiatry and mental health. Established in 1974, this German journal offers a compelling mix of original research, clinical insights, and theoretical discussions, contributing to the advancement of knowledge up to its historical convergence slated for 2024. With a distinguished Scopus ranking of #250 out of 567 in the Psychiatry and Mental Health category, and a 2023 Category Quartile of Q3, it stands as a significant platform for researchers and professionals. The journal does not currently offer Open Access options; however, its reputation and impact within the community place it as a valuable asset for those dedicated to understanding and improving mental health practices. PSYCHIATRISCHE PRAXIS engages its readership with innovative studies and authoritative viewpoints, making it an essential tool for scholars, practitioners, and students aiming to enrich their insight into psychiatric care and research.

BMJ Mental Health, published by the esteemed BMJ PUBLISHING GROUP, is a pioneering open-access journal dedicated to advancing research and knowledge in the field of Psychiatry and Mental Health. Launched in 2023, this journal has rapidly established itself within the academic community, achieving a prestigious Q1 ranking and a ranking of #123 out of 567 in its category, placing it in the 78th percentile according to Scopus. With its base in the United Kingdom, the journal aims to foster impactful research through its commitment to accessibility, allowing professionals, researchers, and students alike to engage with high-quality content freely. The E-ISSN: 2755-9734 enables seamless digital access to cutting-edge studies, reviews, and perspectives that address the complexities of mental health, thereby paving the way for better practices and innovations in mental health care. Join a community of dedicated scholars and practitioners in reshaping the landscape of mental health research with BMJ Mental Health.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

International Journal of Mental Health is a premier academic publication dedicated to the exploration of mental health issues and interventions, encompassing a wide array of disciplines within health policy, psychiatry, and public health. Published by Routledge Journals, Taylor & Francis Ltd, this journal has been contributing significantly to the field since its inception in 1974. With a solid Q2 ranking in various categories including Health Policy, Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health, the journal boasts an impactful platform for scholars and practitioners to disseminate innovative research and contemporary discussions. Although it does not offer open access, readers can access these vital contributions through institutional subscriptions. As the journal continues to address the evolving challenges in mental health, it serves as an essential resource for researchers, healthcare professionals, and policymakers seeking to advance knowledge and improve practices in the mental health arena.

PSYCHIATRIC SERVICES is a leading academic journal published by American Psychiatric Publishing, Inc, dedicated to advancing the understanding and practice of psychiatric care. With a robust ISSN of 1075-2730 and an E-ISSN of 1557-9700, this journal serves as a vital resource for researchers, clinicians, and students in the fields of psychiatry and mental health. Recognized for its high-impact contributions, it holds a prestigious position in the top quartile (Q1) of both the Medicine (miscellaneous) and Psychiatry & Mental Health categories as of 2023, featuring in the Scopus rankings at #164 out of 567, placing it in the 71st percentile. PSYCHIATRIC SERVICES not only provides insights into innovative treatment methodologies and emerging research but also aims to foster a community of knowledge for improving mental healthcare outcomes. While not an Open Access journal, it remains an essential platform for disseminating cutting-edge research from 1995 to 2024 and continues to be an authoritative voice in the dynamic domain of psychiatric services.

Journal of Intellectual Disabilities is a distinguished publication housed under SAGE Publications Ltd, dedicated to advancing the field of intellectual disabilities and enhancing the understanding of associated complexities in health and mental well-being. Established in 2005, this reputable journal stands out with an impressive Scopus rank in the 87th percentile for Health Professions (miscellaneous) and a Q2 quartile ranking, reinforcing its commitment to high-quality research and clinical practice. The journal aims to serve as a vital platform for interdisciplinary discourse among researchers, clinicians, and students, focusing on empirical research, innovative interventions, and policy advocacy to further improve the lives of individuals with intellectual disabilities. Based in the United Kingdom, the journal is not only pivotal in contributing to scholarly discussions but also in shaping the future of practices and policies in the field, making it an essential resource for anyone invested in the mental health and well-being of this population.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.